A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019.

Autor: Kim JY; Department of Internal Medicine, Division of Infectious Diseases, Incheon Medical Center, Incheon, Republic of Korea., Săndulescu O; National Institute for Infectious Diseases 'Prof Dr Matei Balş,' Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Preotescu LL; National Institute for Infectious Diseases 'Prof Dr Matei Balş,' Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Rivera-Martínez NE; Oaxaca Site Management Organization, Oaxaca, Mexico., Dobryanska M; City Clinical Hospital 12, Kyiv, Ukraine.; ARENSIA Exploratory Medicine, Kyiv, Ukraine., Birlutiu V; Faculty of Medicine, Lucian Blaga University of Sibiu, Emergency Clinical County Hospital, Sibiu, Romania., Miftode EG; Clinical Hospital of Infectious Diseases 'Sfanta Parascheva,' University of Medicine and Pharmacy 'Gr. T. Popa,' Iasi, Romania., Gaibu N; Institutul Oncologic din Republica Moldova Republican Clinical Hospital 'T. Moşneaga,' ARENSIA Exploratory Medicine, Chisinau, Moldova., Caliman-Sturdza O; Stefan cel Mare University, Suceava, Romania., Florescu SA; Dr Victor Babes Clinical Hospital for Tropical and Infectious Diseases, Bucharest, Romania., Shi HJ; Department of Internal Medicine, Division of Infectious Diseases, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Streinu-Cercel A; National Institute for Infectious Diseases 'Prof Dr Matei Balş,' Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Streinu-Cercel A; National Institute for Infectious Diseases 'Prof Dr Matei Balş,' Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Lee SJ; Celltrion, Inc, Incheon, Republic of Korea., Kim SH; Celltrion, Inc, Incheon, Republic of Korea., Chang I; Celltrion, Inc, Incheon, Republic of Korea., Bae YJ; Celltrion, Inc, Incheon, Republic of Korea., Suh JH; Celltrion, Inc, Incheon, Republic of Korea., Chung DR; Celltrion, Inc, Incheon, Republic of Korea., Kim SJ; Celltrion, Inc, Incheon, Republic of Korea., Kim MR; Celltrion, Inc, Incheon, Republic of Korea., Lee SG; Celltrion, Inc, Incheon, Republic of Korea., Park G; Celltrion, Inc, Incheon, Republic of Korea., Eom JS; Department of Internal Medicine, Division of Infectious Diseases, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2022 Aug 08; Vol. 9 (8), pp. ofac406. Date of Electronic Publication: 2022 Aug 08 (Print Publication: 2022).

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.

Autor: Lawitz E; Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas., Makara M; Outpatient Clinic, Saint Laszlo Hospital, Budapest, Hungary., Akarca US; Ege University, Faculty of Medicine, Department of Gastroenterology, Izmir, Turkey., Thuluvath PJ; Mercy Medical Center and University of Maryland School of Medicine, Baltimore, Maryland., Preotescu LL; National Institute of Infectious Diseases Prof. Dr. Matei Balş, Bucharest, Romania., Varunok P; Premier Medical Group, New York Medical College, Poughkeepsie, New York., Morillas RM; Liver Section and CIBERehd, Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Hall C; Infectious Diseases Clinical Development, AbbVie Inc, North Chicago, Illinois., Mobashery N; Infectious Diseases Clinical Development, AbbVie Inc, North Chicago, Illinois., Redman R; Infectious Diseases Clinical Development, AbbVie Inc, North Chicago, Illinois., Pilot-Matias T; Infectious Diseases Clinical Development, AbbVie Inc, North Chicago, Illinois., Vilchez RA; Infectious Diseases Clinical Development, AbbVie Inc, North Chicago, Illinois., Hézode C; Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, AP-HP, Université Paris-Est, INSERM U955, Créteil, France. Electronic address: christophe.hezode@hmn.aphp.fr.

Publikováno v: Gastroenterology [Gastroenterology] 2015 Oct; Vol. 149 (4), pp. 971-80.e1. Date of Electronic Publication: 2015 Jul 11.